GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Board Meeting Scheduled for Q2 & H1 FY27 Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Oct 2026, 12:27 PM IST  ·  BSE ID: 120a82cf-ca40-4d95-9ef1-93ccd61a8e87
View Original BSE Filing (PDF)
💡
In Simple Terms
SMS Pharmaceuticals will hold a board meeting on November 4, 2026, to review its financial results for the latest quarter.
🤖 AI Summary
  • SMS Pharmaceuticals Board Meeting on November 4, 2026, to approve Q2 and H1 FY27 financial results.
  • The meeting will consider Unaudited Standalone and Consolidated Financial Results for period ended September 30, 2026.
  • Trading window for company equity shares closed from October 1, 2026, until November 6, 2026.
  • Trading window for designated persons will reopen on November 7, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this intimation of a future board meeting.
👤
Who Is Affected
Shareholders will be affected by the trading window closure from October 1, 2026, to November 6, 2026, restricting trading by designated persons. All shareholders will receive the Q2 and H1 FY27 financial results after the board meeting.
🔍
Management Signal
The scheduling of the board meeting and timely intimation of trading window closure indicates adherence to SEBI (LODR) Regulations, 2015, and SEBI (Prohibition of Insider Trading) Regulations, 2015.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome for Q2 and H1 FY27 financial results on November 4, 2026.
Review of Unaudited Standalone Financial Results for Q2 and H1 FY27.
Review of Unaudited Consolidated Financial Results for Q2 and H1 FY27.
LOW RISK The filing is a routine intimation of a board meeting for financial results, carrying no inherent risks.
💡 Investor Takeaway
SMS Pharmaceuticals Limited has scheduled a Board Meeting for November 4, 2026, to consider and approve its Unaudited (Standalone and Consolidated) Financial Results for the second quarter and half year ended September 30, 2026. A trading window closure is in effect from October 1, 2026, to November 6, 2026.
📅 Company Track Record
SMS Pharma's Q1 FY27 revenue rose 6% YoY to ₹207.0 Cr, with PAT up 8% YoY, as reported in the August 1, 2026, press release on financial results. This upcoming board meeting follows the schedule set for Q1 FY27 results which were approved on August 1, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the next Board Meeting for SMS Pharmaceuticals Limited?
The next Board Meeting for SMS Pharmaceuticals Limited is scheduled to be held on Wednesday, November 4, 2026.
What is the purpose of the SMS Pharmaceuticals Board Meeting on November 4, 2026?
The purpose of the Board Meeting on November 4, 2026, is to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the second quarter and half year ended on September 30, 2026.
When is the trading window closed for SMS Pharmaceuticals Limited shares?
The trading window for SMS Pharmaceuticals Limited equity shares for designated persons is closed from October 1, 2026, up to November 6, 2026 (both days inclusive).
When will the trading window for SMS Pharmaceuticals Limited shares reopen?
The trading window for SMS Pharmaceuticals Limited equity shares for designated persons shall be re-opened on November 7, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.